Analytical Chemistry · 2021 · 24 citations · 45 references
MedicineBiochemistryOncologyCellular MetabolismMolecular OncologyTumor HeterogeneityBrain TumorsCancer MetabolismGlioblastomaMetabolic HeterogeneityMetabolic ReprogrammingTumor BiologyAnticancer ActivityElemental ImagingGlioblastoma MetabolismHard X-ray SpectroscopyRiluzole TherapyRiluzole TreatmentTumor Cell MetabolismTumor Metabolism
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, characterized by short median survival and an almost 100% tumor-related mortality. The standard of care treatment for newly diagnosed GBM includes surgical resection followed by concomitant radiochemotherapy. The prevention of disease progression fails due to the poor therapeutic effect caused by the great molecular heterogeneity of this tumor. Previously, we exploited synchrotron radiation-based soft X-ray tomography and hard X-ray fluorescence for elemental microimaging of the shock-frozen GBM cells. The present study focuses instead on the biochemical profiling of live GBM cells and provides new insight into tumor heterogenicity. We studied bio-macromolecular changes by exploring the live-cell synchrotron-based Fourier transform infrared (SR-FTIR) microspectroscopy in a set of three GBM cell lines, including the patient-derived glioblastoma cell line, before and after riluzole treatment, a medicament with potential anticancer properties. SR-FTIR microspectroscopy shows that GBM live cells of different origins recruit different organic compounds. The riluzole treatment of all GBM cell lines mainly affected carbohydrate metabolism and the DNA structure. Lipid structures and protein secondary conformation are affected as well by the riluzole treatment: cellular proteins assumed cross β-sheet conformation while parallel β-sheet conformation was less represented for all GBM cells. Moreover, we hope that a new live-cell approach for GBM simultaneous treatment and examination can be devised to target cancer cells more specifically, i.e., future therapies can develop more specific treatments according to the specific bio-macromolecular signature of each tumor type.
45
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons, Siân Jones, Xiaosong Zhang et al. · Science · 2008 · 5.8K citations · Full text
Using Fourier transform IR spectroscopy to analyze biological materials
Matthew J. Baker, Júlio Trevisan, Paul Bassan et al. · Nature Protocols · 2014 · 1.9K citations · Full text
Transforming Fusions of <i>FGFR</i> and <i>TACC</i> Genes in Human Glioblastoma
Devendra Raj Singh, Joseph M. Chan, Pietro Zoppoli et al. · Science · 2012 · 784 citations · Full text